Vyriad Inc. Names Experienced Life Sciences Investors Edwin Kania and Nathan Stacy to its Board of Directors View more
Regeneron and Vyriad Announce Strategic Agreement for Discovery and Development of New Oncolytic Virus Treatments for Cancer View more
Francis Medical Launches With $18M SERIES A Funding for Promising Cancer Ablation Technology Using Water Vapor View more
